Advertisement

Pathologie der Kardiomyopathien und Myokardiopathien

  • S. Hauptmann
  • R. Poche

Zusammenfassung

Eine Kardiomyopathie (CM) ist eine myokardiale Herzkrankheit unbekannter oder bekannter Ätiologie, bei der ein stark vergrößertes Herz mit charakteristischen hämodynamischen Veränderungen im Vordergrund des Krankheitsbildes steht.

Eine Myokardiopathie (MC) ist eine myokardiale Herzkrankheit mit meistens bekannter Ätiologie — entzündlich, metabolisch, toxisch, physikalisch-, bei der das Herz entweder direkt betroffen ist oder im Rahmen einer Allgemeinerkrankung miterkränkt, und die nach Fortfall der auslösenden Noxe bzw. nach Überstehen der Allgemein-erkrankung entweder komplett oder mit Defektbildung ausheilen oder aber auch in eine Kardiomyopathie einmünden kann.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Albertini A v (1953) Zur Pathogenese des rheumatischen Granuloms. Schweiz med Wschr 83:772Google Scholar
  2. Anitschkow N (1913) Experimentelle Untersuchungen über die Neubildung des Granulationsgewebes im Herzmuskel. Beitr path Anat 55:373Google Scholar
  3. Arbustini E, Gavazzi A, Pozzi R et al (1989) The morphologic spectrum of dilated cardiomyopathy and its relation to immune response genes. Am J Cardiol 64:991PubMedCrossRefGoogle Scholar
  4. Aretz HT, Southern JF, Palacios IF et al (1987) Morphological and immunological findings in heart biopsies of patients with suspected or treated myocarditis. Eur Heart J 8 (Suppl J):187Google Scholar
  5. Baroldi G, Corallo S, Moroni M et al (1988) Focal lymphocytic myocarditis in aquired immunodeficience syndrome (AIDS): A correlative morphologic and clinical study in 26 consecutive fatal cases. J Am Coll Cardiol 12:463PubMedCrossRefGoogle Scholar
  6. Barth PG, Schölte HR, Berden JA et al (1983) An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J Neurol Sci 62:327PubMedCrossRefGoogle Scholar
  7. Becker BJP, Chatgidakis CB, Lingen B v (1953) Cardiovascular collagenosis with parietal endocardial thrombosis. Circulation 7:345PubMedGoogle Scholar
  8. Bedford DE, Konstam GLS (1946) Heart failure of unknown cause in Africans. Br Heart J 8:236PubMedCrossRefGoogle Scholar
  9. Bell JA, Jenkins BS, Webb-Peploe MM (1976) Clinical, hemodynamic and angiographic findings in Löffler’s eosinophilic endocarditis. Br Heart J. 38:541PubMedCrossRefGoogle Scholar
  10. Bely M, Apathy A (1991) Herzveränderungen bei chronischer Polyarthritis. Zbl Path 137:325Google Scholar
  11. Benjamin IJ, Jalil JE, Tan LB et al (1989) Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res 65:657PubMedGoogle Scholar
  12. Berko BA, Swift M (1987) X-lined dilated cardiomyopathy. N Engl J Med 316:1186PubMedCrossRefGoogle Scholar
  13. Bestetti RB (1989) Cardiac involvement in the aquired immune deficiency syndrome. Int J Cardiol 22:143PubMedCrossRefGoogle Scholar
  14. Bierhoff E, Jung W, Manz M (1992) Zur arrhythmogenen rechtsventrikulären Dysplasie. Pathologe 13:141PubMedGoogle Scholar
  15. Billingham M (1987) Acute myocarditis: a diagnostic dilemma. Br Heart J 58:6PubMedCrossRefGoogle Scholar
  16. Böhm M, Gierschick P, Knorr A et al (1992) Role of altered G-protein expression in the regulation of myocardial adenylate cyclase activity and force of contraction in spontaneous hypertensive cardiomyopathy in rats. J Hypertension 10:1115CrossRefGoogle Scholar
  17. Braunwald E, Aygen M (1963) Idiopathic myocardial hypertrophy without congestive heart failure or obstruction to blood flow. Am J Med 35:7PubMedCrossRefGoogle Scholar
  18. Brigden W (1957) Uncommon myocardial diseases, the non-coronary cardiomyopathies. Lancet 11:1179 u. 1243CrossRefGoogle Scholar
  19. Brockington IF, Olsen EGJ (1973) Löffler’s endocarditis and Davies’ endomyocardial fibrosis. Am Heart J 65:308CrossRefGoogle Scholar
  20. Bulkley BH, D’Amico B, Taylor AL (1983) Extensive myocardial fiber disarrey in aortic and pulmonary atresia — relevance to hypertrophic cardiomyopathy. Circulation 67:192CrossRefGoogle Scholar
  21. Burger DR, Jones RE, Vetto RM et al. (1987) Accessory cell function of the endothelial cells: its role in the cellular immune response. Int J Tissue React 9:365PubMedGoogle Scholar
  22. Cenac A, Beaufils H, Soumana I et al (1990) Absence of humoral autoimmunity in peripartum cardiomyopathy. A comparative study in Niger. Int J Cardiol 26:49PubMedCrossRefGoogle Scholar
  23. Channer KS, Channer JL, Campbell MJ et al (1988) Cardiomyopathy in the Kearns-Sayre syndrome. Br Heart J 59:486PubMedCrossRefGoogle Scholar
  24. Chew CYC, Ziady GM, Raphael MJ et al (1977) Primary restrictive cardiomyopathy. Br Heart J 39:399PubMedCrossRefGoogle Scholar
  25. Cho T, Tanimura A, Saito Y (1987) Catecholamine-induced cardiomyopathy accompanied with pheochromocytoma. Acta Path Jpn 37:123Google Scholar
  26. Cookston M, Stober M, Kayes SG (1990) Eosinophilie myocarditis in CBA/J mice infected with Toxocara canis. Am J Pathol 136:1137PubMedGoogle Scholar
  27. Correa-Araujo R, Oliveira JSM, Ricciardi-Cruz A (1991) Cardiac Chages disease. Int J Cardiol 31:329PubMedCrossRefGoogle Scholar
  28. Costanzo-Nordin MR, Silver MA, O’Connell JB et al (1987) Giant cell myocarditis dramatic hemodynamic and histologic improvement with immunosuppressive therapy. Eur Heart J 8 (Suppl J):271Google Scholar
  29. Cox JN, Dio F, Pizzolanto G-P et al (1990) Aspergillus endocarditis and myocarditis in patients with the aquired immunodeficiency syndrome (AIDS): A review of the literature. Vir-chows Arch A 417:255CrossRefGoogle Scholar
  30. Czanady M, Högye M, Forster T (1987) Hypertrophie cardiomyopathy associated with congenital deaf-mutism. Eur Heart J 8:528Google Scholar
  31. Davies J, Spry CJ, Vijayaraghavan G et al (1983) A comparison of the clinical and cardiological features of endomyocardial disease in temperate and tropical regions. Postgrad Med J 59:179PubMedCrossRefGoogle Scholar
  32. Doerr W (1952) Die „basophile (mukoide) Degeneration“ des Herzmuskels. Z Kreisl-Forsch 41:42Google Scholar
  33. Doerr W (1967) Entzündliche Erkrankungen des Myokard. Verh Dtsch Ges Path 51:67Google Scholar
  34. Doerr W (1970) Allgemeine Pathologie der Organe des Kreislaufes. In: Hdb allg Path, Bd III/4, S 205. Springer, Berlin Heidelberg New YorkGoogle Scholar
  35. Dong R, Liu P, Wee L et al (1992) Verapamil ameliorates the clinical and pathological course of murine myocarditis. J Clin Invest 90:2022PubMedCrossRefGoogle Scholar
  36. Downings SE, Chen V (1985) Myocardial injury following endogenous catecholamine release in rabbits. J Mol Cell Cardiol 17:377CrossRefGoogle Scholar
  37. Ekeren GJ van, Stadhouders AM, Egbrink GJM et al (1987) Hereditary mitochondrial hypertrophic cardiomyopathy of skeletal muscle, congenital cataract and lactic acidosis. Vir-chows Arch A 412:47CrossRefGoogle Scholar
  38. Epstein SE, Henry WL, Clark CE et al (1974) Asymmetric septal hypertrophy. Ann Intern Med 81:650Google Scholar
  39. Falase AO (1983) Endomyocardial fibrosis in Africa. Postgrad Med J 59:170PubMedCrossRefGoogle Scholar
  40. Fassbender HG (1963) Nosologische Typen des rheumatischen Granuloms und ihre biologische Bedeutung. Frankf Z Path 72:586Google Scholar
  41. Fassbender HG (1975) Pathologie rheumatischer Erkrankungen. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  42. Ferrans VJ, Rodriguez ER, McAllister HA (1985) Granulomatous inflammation of the heart. Heart a Vessels, Suppl 1:265Google Scholar
  43. Flegel H-G, Meyer R, Förster A (1991) Zum Vorkommen der Vaskulitis in Endomyokardialbiopsien bei chronischer Myokarditis. Z klin Med 46:531Google Scholar
  44. Fontaine G, Fontaliran F, Frank R et al (1988) La dysplasie ven-triculaire. Nosologie et mort subie. Ann Cardiol Angiol Paris 37:347Google Scholar
  45. Gach IV, Andriange M, Frank G (1971) Hypertrophie obstructive cardiomyopathy and Friedreich’s ataxia. Am J Cardiol 27:436PubMedCrossRefGoogle Scholar
  46. Gauntt CJ, Arizpe HM, Higdon AL et al (1991) Anti-cox-sackievirus B 3 neutralizing antibodies with pathological potential. Eur Heart J 12 (Suppl D):124PubMedGoogle Scholar
  47. Geisterfer-Lawrence A, Kass S, Tanigawa G et al (1990) A molecular basis for familial hypertrophic cardiomyopathy: A ß cardiac myosin heavy chain gene missence mutation. Cell 62:999CrossRefGoogle Scholar
  48. Gelb AB, Meter SH van, Billingham ME et al (1993) Infantile histiocytoid cardiomyopathy — myocardial or conduction system hamartoma. Hum Path 24:1226PubMedCrossRefGoogle Scholar
  49. Goodwin JF (1970) Congestive and hypertrophic cardiomyopathies. A decade of study. Lancet 1:731CrossRefGoogle Scholar
  50. Gries W, Farkas D, Winters GL et al (1992) Giant cell myocarditis; first report of disease recurrence in the transplanted heart. J Heart Lung Transplant 11:370PubMedGoogle Scholar
  51. Grody WW, Cheng L, Lewis W (1990) Infection of the heart by the human immunodeficiency virus. Am J Cardiol 66:203PubMedCrossRefGoogle Scholar
  52. Gross WL (1982) Lymphozytenantwort auf human-pathogene Streptokokken. Copythek. Thieme, StuttgartGoogle Scholar
  53. Hardy WR, Anderson RE (1968) The hypereosinophilic syndromes. Ann Intern Med 68:1220PubMedGoogle Scholar
  54. Harmjanz D, Reale E, Luciano L et al (1971) Die Endomyokard-biopsie als Hilfsmittel in der Diagnostik und Myokarder-krankungen. Verh dtsch Ges inn Med 77:1263PubMedGoogle Scholar
  55. Harris LC, Powell G, Brown OW (1978) Primary myocardial disease. Endocardial fibroelastosis. Pediatr Clin North Am 25:847PubMedGoogle Scholar
  56. Herzog CA, Snover DC, Stanley NA (1984) Acute necrotizing eosinophilic myocarditis. Br Heart J 52:343PubMedCrossRefGoogle Scholar
  57. Herzum M, Maisch B (1992) Humorale und zelluläre Immunreaktionen gegen das Herz bei Patienten mit Myokarditis. Herz 17:91PubMedGoogle Scholar
  58. Hiraoka Y, Kishimoto C, Kurakawa M et al (1992) Effects of polyethylene glycol conjugated superoxide dismutase on coxsackievirus B3 myocarditis in mice. Cardiovasc Res 26:956PubMedCrossRefGoogle Scholar
  59. Hsiao Y-C, Suzuki K, Abe H et al (1987) Ultrastructural alterations in cardiac muscle of diabetic BB Wistar rats. Virchows Arch A 411:45CrossRefGoogle Scholar
  60. Hsieh C-C, Chiang C-W, Hsieh T-T et al (1992) Peripartum cardiomyopathy. Jpn Heart J 33:342CrossRefGoogle Scholar
  61. Huber SA (1992) Heat-shock protein induction in adriamycin and picornavirus-infected cardiomyocytes. Lab Invest 67:218PubMedGoogle Scholar
  62. Hübner G, Gokel JM, Pongratz D et al (1986) Fatal mitochondrial cardiomyopathy in Kearns-Sayre syndrome. Virchows Arch A 408:611CrossRefGoogle Scholar
  63. Hutt MS (1970) Pathology of African cardiomyopathies. Pathol Microbiol 35:37Google Scholar
  64. Iao T, Sherwood WG, Cutz E et al (1988) Dilated car-diomyopathia with neutropenia, short stature, and abnormal carnitine metabolism. J Pediat 113:511CrossRefGoogle Scholar
  65. Izumi T, Kodema M, Shibata A (1991) Experimental giant cell myocarditis induced by cardiac myosin immunization. Eur Heart J 12 (Suppl D):166PubMedGoogle Scholar
  66. Jaski BE, Goetzl E J, Said JW et al (1978) Endomyocardial disease and eosinophilia. Report of a case. Circulation 57:824PubMedGoogle Scholar
  67. Jin O, Sole MJ, Butany JW et al (1990) Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation 82:8PubMedCrossRefGoogle Scholar
  68. Joshi VV, Gadol C, Conner E et al. (1988) Dilated cardiomyopathy in children with aquired immunodeficiency syndrom: a pathologic study of five cases. Hum Path 19:69PubMedCrossRefGoogle Scholar
  69. Kajihara H, Oda N, Tahara E et al (1986) Histopathologic observations of the heart with diffuse and abnormal proliferation of mitochondria in myocardial cells (mitochondrial cardiomyopathy): report of an adult case. Heart a Vessels 2:233CrossRefGoogle Scholar
  70. Kaltenbach M (1978) Terminology. In: Kaltenbach M, Loogen F, Olsen EGJ (Hrsg) Cardiomyopathy and myocardial biopsy, S XIII. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  71. Katz AM, Freston JW, Messineo FC et al (1985) Membrane damage and the pathogenesis of cardiomyopathies. J Molec Cell Cardiol (Suppl 2): 11Google Scholar
  72. Kauffman SL, Chandra N, Peress NS et al (1972) Idiopathic infantile cardiomyopathy with involvement of the conduction system. Am J Cardiol 30:648PubMedCrossRefGoogle Scholar
  73. Kawamura O, Ohaki Y, Nakatani Y et al (1986) Idiopathic right ventricular dilatation. Special reference to “arrhythmogenic right ventricular dysplasia” and analogous lesions. Acta Path Jpn 36:1693Google Scholar
  74. Kishimoto C, Abelmann WH (1989) Monoclonal antibody therapy for prevention of acute coxsackievirus B 3 myocarditis in mice. Circulation 79:1300PubMedCrossRefGoogle Scholar
  75. Klinge E (1933) Der Rheumatismus. Ergebn allg Path 27:1Google Scholar
  76. Knieriem H-J (1978) Electron-microscopic findings in congestive cardiomyopathy. In: Kaltenbach M, Loogen F, Olsen EGJ (Hrsg) Cardiomyopathy and myocardial biopsy, S 71. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  77. Knieriem H-J, Krayenbühl HP, Meessen H et al (1970) Die Ultrastruktur des Myokards bei experimenteller Herzinsuffizienz durch hypertone Kochsalzinfusionen. Z Kreisl-Forsch 59:972Google Scholar
  78. Knieriem H-J, Kuhn H, Breithardt G (1975) Morphologische Befunde bei Myokardbiopsien. Verh Dtsch Ges Path 59:470Google Scholar
  79. Kodama M, Zhang S, Hanawa AH et al (1992) Immunohisto-chemical characterization of infiltrating mononuclear cells in rat heart with experimental autoimmune giant cell myocarditis. Clin Exp Immunol 90:330PubMedCrossRefGoogle Scholar
  80. Kotaka M, Kitaura Y, Deguchi H et al (1990) Experimental influença A virus myocarditis in mice: light and electron microscopic, virologie, and hemodynamic study. Am J Path 136:409PubMedGoogle Scholar
  81. Kothari SS (1991) Pathogenesis of hypertrophic cardiomyopathy: another viewpoint. Int J Cardiol 30:9PubMedCrossRefGoogle Scholar
  82. Kühl U, Daun B, Seeberg B et al (1992) Immunhistologische Charakterisierung lymphozytärer Infiltrate. Herz 17:97PubMedGoogle Scholar
  83. Kuhn H, Breithardt G, Knieriem H-J et al (1975) Die Bedeutung der endomyokardialen Katheterbiopsie für die Diagnostik und Beurteilung der Prognose bei congestiver Cardiomyopathie. Dtsch med Wschr 100:717 u. 743PubMedCrossRefGoogle Scholar
  84. Kuhn H, Breithardt G, Knieriem H-J et al (1978) Endomyocardial catheter biopsy in heart disease of unknown etiology. In: Kaltenbach M, Loogen F, Olsen EGJ (Hrsg) Cardiomyopathy and myocardial biopsy, S 121. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  85. Kuhn H, Mercier J, Köhler E et al (1983) Differential diagnosis of hypertrophic cardiomyopathies: typical (subaortic) hypertrophic obstructive cardiomyopathy, atypical (midven-tricular) hypertrophic obstructive cardiomyopathy and hypertrophic non-obstructive cardiomyopathy. Eur Heart J 4 (Suppl F):93PubMedGoogle Scholar
  86. Kurki P, Karjalainen J, Hautanen A et al (1989) Desmin antibodies in acute infectious Myopericarditis. APMIS 97:527PubMedCrossRefGoogle Scholar
  87. Langer E (1954) Beitrag zur Endocarditis parietalis fibroplastica (Löffler). Verh dtsch Ges Kreisl-Forsch 20:242Google Scholar
  88. Langes K, Frenzel H, Seitz RJ et al (1985) Cardiomyopathy associated with Leigh’s disease. Virchows Arch A407:97Google Scholar
  89. Lee JC, Sponenberg DP (1985) Role of alpha-1-adrenoreceptors in norepinephrine-induced cardiomyopathy. Am J Path 121:316PubMedGoogle Scholar
  90. Lewis W (1989) AIDS: Cardiac findings from 115 autopsies. Progr Cardiovasc Dis 32:204CrossRefGoogle Scholar
  91. Liebegott G (1936) Über die „basophile Degeneration der Herzmuskelfaser“, ein Beitrag zu den „vitalen Reaktionen“. Beitr path Anat 98:410Google Scholar
  92. Limas CJ, Limas C (1991) Beta-adrenoreceptor antibodies and genetics in dilated cardiomyopathy — an overview and review. Eur Heart J 12 (Suppl D):175PubMedGoogle Scholar
  93. Löffler W (1936) Endocarditis parietalis fibroplastica mit Bluteosinophilie. Ein eigenartiges Krankheitsbild. Schweiz med Wschr 66:817Google Scholar
  94. London GM, Fabiani F, Marchais SJ et al (1987) Uremie cardiomyopathy: An inadequate left ventricular hypertrophy. Kidney Int 31:973PubMedCrossRefGoogle Scholar
  95. Loogen F, Kuhn H, Neuhaus LK (1977) Störungen der Ventrikelfunktion bei Kardiomyopathien. Verh dtsch Ges Kreisl-Forsch 42:63Google Scholar
  96. MacArthur CGC, Tarin D, Goodwin JF et al (1984) The relationship of myocarditis to dilated cardiomyopathy. Eur Heart J 5:1023PubMedGoogle Scholar
  97. MacClure E, Poche R (1960) Die experimentelle Chagas-Myo-karditis der weißen Maus im elektronenmikroskopischen Bild. Virchows Arch path Anat 333:405CrossRefGoogle Scholar
  98. Maisch B, Izumi T (1985) Cardiomyopathy and myocarditis -a review of new aspects in research in West Germany. Heart a vessels (Suppl 1):8Google Scholar
  99. Maron BJ, Ferrans VJ, Henry WL et al (1974) Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH): Light- and electronmicroscopic findings. Circulation 50:436PubMedGoogle Scholar
  100. Maron BJ, Kragel AH, Roberts WC (1990) Sudden death in hypertrophic cardiomyopathy with normal left ventricular mass. Br Heart J 63:308PubMedCrossRefGoogle Scholar
  101. Meessen H, Poche R (1967) Beiträge zur pathologischen Anatomie der Fallotschen Fehler und zur idiopathischen Herzhypertrophie. Dtsch-engl med Rdsch (Anglo-germ med Rev) 4:73Google Scholar
  102. Menges H, Brandenburg RO, Brown AL (1961) The clinical hemodynamics, and pathologic diagnosis of muscular sub-valvular aortic stenosis. Circulation 24:1126PubMedGoogle Scholar
  103. Molina HA, Kierszenbaum F (1988) Immunohistochemical detection of deposits of eosinophilderived neurotoxin and eosinophil peroxidase in the myocardium of patients with Chagas’ disease. Immunology 64:725PubMedGoogle Scholar
  104. Müller S (1989) Dilatative Kardiomyopathie — Herzmuskelerkrankung ungeklärter Ursache oder Autoimmunerkrankung? Neue Aspekte zur Ätiologie, Pathogenese und Klinik. Z ges Inn Med 44:469PubMedGoogle Scholar
  105. Müller-Höcker J, Seibel P, Schneiderbanger K et al (1992) In situ hybridization of mitochondrial DNA in the heart of a patient with Kearns-Sayre syndrome and dilatative cardiomyopathy. Hum Pathol 23:1431PubMedCrossRefGoogle Scholar
  106. Murphy GE (1960) Nature of rheumatic heart disease. Medicine 30:289Google Scholar
  107. Nakayama T, Kohriyama T, Yamamoto S et al (1985) Electron-microscopic and immunohistochemical studies on endomyocardial biopsies from a patient with eosinophilic endomyocardial disease. Heart a Vessels (Suppl 1):250Google Scholar
  108. Neustein HB, Lurie PR, Dahms P et al (1979) An X-linked recessive cardiomyopathy with abnormal mitochondria. Pediatrics 64:24PubMedGoogle Scholar
  109. Nicod P, Polikar R, Peterson KL (1988) Hypertrophic cardiomyopathy and sudden death. N Engl J Med 318:1255PubMedCrossRefGoogle Scholar
  110. Nunoda S, Genda A, Sugihara N et al (1985) Quantitative approach to the histopathology of the biopsied right ventricular myocardium in patients with diabetes mellitus. Heart a Vessels 1:43CrossRefGoogle Scholar
  111. Oaklay CM, Olsen EG (1977) Eosinophilia and heart disease. Br Heart J 39:233CrossRefGoogle Scholar
  112. Obayashi T, Hattori K, Sugiyama S et al (1992) Point mutations in mitochondrial DNA in patients with hypertrophic cardiomyopathy. Am Heart J 124:1263PubMedCrossRefGoogle Scholar
  113. Olsen EGJ (1987) Morphological aspects of myocarditis and pericarditis. Eur Heart J 8 (Suppl J):11Google Scholar
  114. Olsen EGJ, Spry CJF (1979) The pathogenesis of Loeffler’s endomyocardial disease, and its relationship to endomyocardial fibrosis. In: Yu PN, Goodwin JF (Hrsg) Progress in cardiology, Vol 8:281. Lea & Febiger, PhiladelphiaGoogle Scholar
  115. Ono K (1990) Oxalate crystal deposits in the heart in chronic renal failure: An experimental study. Nephrol Dial Transplant 5:493PubMedGoogle Scholar
  116. Paraf F, Py A, Pauly-Laubry C et al (1990) Pathology of the heart in the human immunodeficiency virus infection. Arch Anat Cytol Pathol 38:171PubMedGoogle Scholar
  117. Parrillo JE, Borer JS, Henry WL et al (1979) The cardiovascular manifestation of the hypereosinophilic syndrome. Am J Med 67:572PubMedCrossRefGoogle Scholar
  118. Patel AK, d’Arbela PG, Sommers K (1977) Endomyocardial fibrosis and eosinophilia. Br Heart J 39:238PubMedCrossRefGoogle Scholar
  119. Pearse AGE (1964) The histochemistry and electron microscopy of obstructive cardiomyopathy. In: Wolstenholme GEW, O’Connor M (Hrsg) Cardiomyopathies. Ciba Foundation Symposium, S 132. Churchill, LondonCrossRefGoogle Scholar
  120. Pellica F, Gallo P, Cianfrocca C et al (1990) Relation of complex ventricular arrhythmias to presenting features and prognosis in dilated cardiomyopathia. Int J Cardiol 29:47CrossRefGoogle Scholar
  121. Poche R (1958) Submikroskopische Beiträge zur Pathologie der Herzmuskelzelle bei Phosphorvergiftung. Hypertrophie, Atrophie und Kaliummangel. Virchows Arch path Anat 331:165CrossRefGoogle Scholar
  122. Polani PF, Moynahan EJ (1972) Progressive cardiomyopathic lentiginosis. Q J Med 42:205Google Scholar
  123. Regitz V, Olsen EGJ, Rudolph W (1985) Histologisch nachweisbare Myokarditis bei Patienten mit eingeschränkter linksven-trikulärer Funktion. Herz 10:27PubMedGoogle Scholar
  124. Reh H, Haarhoff K, Honus S (1987) Plötzlicher Tod bei Alko-hol-Kardiomyopathie. Lebensversicherungsmedizin 39: 89PubMedGoogle Scholar
  125. Reifferscheid M (1972) Chirurgie. Thieme, StuttgartGoogle Scholar
  126. Reinbach G (1893) Über das Verhalten der Leukozyten bei malignen Tumoren. Arch klin Chir 46:486Google Scholar
  127. Roberts WC, Liegler DG, Carbone PP (1969) Endomyocardial disease and eosinophilia. A clinical and pathologic spectrum. Am J Med 46:28PubMedCrossRefGoogle Scholar
  128. Roberts WC, Waller BF (1983) Cardiac amyloidosis causing cardiac dysfunction: Analysis of 54 necropsy patients. Am J Cardiol 52:137PubMedCrossRefGoogle Scholar
  129. Rodrigues B, McNeill JH (1992) The diabetic heart: metabolic causes for the development of a cardiomyopathy. Cardiovasc Res 26:913PubMedCrossRefGoogle Scholar
  130. Rönnblom LE, Forsberg H, Evrin PE (1991) Increased level of HLA-DR-expressing T lymphocytes in peripheral blood from patients with idiopathic dilated cardiomyopathy. Cardiology 78:161PubMedCrossRefGoogle Scholar
  131. Rona G (1985) Catecholamin cardiotoxity. J Mol Cell Cardiol 17:291PubMedCrossRefGoogle Scholar
  132. Rossi E (1976) Die Fibroelastosis endocardica (FE) und ihre Differentialdiagnose. Pediatr Pathol 11:23Google Scholar
  133. Schmaltz AA (1991) Die Myokarditis im Kindesalter. Klin Pä-diat 203:1CrossRefGoogle Scholar
  134. Schmincke A (1907) Über linksseitige muskulöse Konusstenosen. Dtsch med Wschr 33:2082CrossRefGoogle Scholar
  135. Schultheiß H-P (1987) The mitochondrium as antigen in inflammatory heart disease. Eur Heart J 8 (Suppl J):203Google Scholar
  136. Selye H (1958) Production of an “electrolyte-steroid-car-diopathy” with NaC104 and its prevention by MgCl2 and KCl. Angiology 9:262PubMedCrossRefGoogle Scholar
  137. Shankar PS (1981) Congenital heart diseases. Q Med Rev 32:1PubMedCrossRefGoogle Scholar
  138. Shaper AG, Hutt MSR, Coles RM (1968) Necropsy study of endomyocardial fibrosis and rheumatic heart disease in Uganda. Br Heart J 30:391PubMedCrossRefGoogle Scholar
  139. Sobernheim JF (1837) Praktische Diagnostik der inneren Krankheiten mit vorzüglicher Rücksicht auf pathologische Anatomie, S 118. Hirschwald, BerlinGoogle Scholar
  140. Solomon SD, Jarcho DA, McKenna W et al (1990) Familial hypertrophic cardiomyopathy is a genetically heterogenous disease. J Clin Invest 86:993PubMedCrossRefGoogle Scholar
  141. Sommers K, Hutt MSR, Patel AK et al (1971) Endomyocardial biopsy in diagnosis of cardiomyopathies. Br Heart J 33:822CrossRefGoogle Scholar
  142. Soos I, Facsko A, Edes I et al (1991) Effects of chronic alcohol ingestion on myocardial lipid and fatty acid composition in adult turkeys. Cardiovasc Res 25:881PubMedCrossRefGoogle Scholar
  143. Spirito P, Chiarella F, Carratino L et al (1989) Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med 320:749PubMedCrossRefGoogle Scholar
  144. Spry CJ (1982) The hypereosinophilic syndrome: clinical features, laboratory findings and treatment. Allergy 37:539PubMedCrossRefGoogle Scholar
  145. Spry CJF, Tai P-C (1987) The eosinophil in myocardial disease. Eur Heart J 8 (Suppl J):81Google Scholar
  146. Spry CJF, Take M, Tai P-C (1985) Eosinophilic disorders affecting the myocardium: a review. Heart a Vessels (Suppl 1):240CrossRefGoogle Scholar
  147. Staemmler M (1955) Die Kreislauforgane. In: Kaufmann E, Staemmler M (Hrsg) Lehrbuch der speziellen pathologischen Anatomie. Erg-Bd 1/1, S 1. de Gruyter, BerlinGoogle Scholar
  148. Steinsapir K, Lewis W (1985) Dilated cardiomyopathy associated with Friedreich’s ataxia. Arch Path Lab Med 109:454PubMedGoogle Scholar
  149. Stronzek DF, Vercelotti GM, Huh PW et al (1986) Neutrophil oxidants inactivate alpha 1-protease inhibitor and promote PMN-mediated detachment of cultured endothelium. Arteriosclerosis 6:332CrossRefGoogle Scholar
  150. Suomalainen A, Paetau A, Leinonen H et al (1992) Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA. Lancet 340:1319PubMedCrossRefGoogle Scholar
  151. Tanaka M, Kawahara Y, Motomiya T et al (1989) Cardiomyopathy characterized by abnormal accumulation of desmin-type intermediate filaments in cardiac muscle fibers: a case report and review of the literature. Acta Pathol Japon 39:266Google Scholar
  152. Tanigawa G, Jarcho JA, Kass A et al (1990) A molecular basis for familial hypertrophic cardiomyopathy: An α/β cardiac myosin heavy chain hybrid gene. Cell 62:991PubMedCrossRefGoogle Scholar
  153. Tardieu M, Powers ML, Haller DA et al (1984) Autoimmunity following viral infection: Demonstration of monoclonal antibodies against normal tissue following infection of mice with reovirus and demonstration of shared antigenicity between virus and lymphocytes. Eur J Immunol 14:561PubMedCrossRefGoogle Scholar
  154. Thiene G, Nava A, Corrado D et al (1988) Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 318:129PubMedCrossRefGoogle Scholar
  155. Valiathan SM, Kartha CC (1990) Endomyocardial fibrosis -the possible connexion with myocardial levels of magnesium and cerium. Int J Cardiol 28:1PubMedCrossRefGoogle Scholar
  156. Vikhert AM, Tsiplenkova VG, Cherpachenko NM (1986) Alcoholic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol 8:3AGoogle Scholar
  157. Virchow R (1858) Die Cellularpathologie in ihrer Begründung auf physiologische und pathologische Gewebelehre. Hirschwald, BerlinGoogle Scholar
  158. Voelker W, Schick KD, Karsch KR (1989) Myocardial bridges at multiple sites over the left coronary artery in a patient with hypertrophic cardiomyopathy. Int J Cardiol 23:258PubMedCrossRefGoogle Scholar
  159. Vybiral T, Deitiker PR, Roberts R et al (1992) Accumulation and assembly of myosin in hypertrophic cardiomyopathy with the 403 Arg to Gin ß-myosin heavy chain mutation. Circul Res 71:1404Google Scholar
  160. Walshe WH (1873) Disease of the heart and great vessels. Smith Elder, LondonGoogle Scholar
  161. Watkis H, Thierfelder L, Hwang D-S et al (1992) Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations. J Clin Invest 90:1666CrossRefGoogle Scholar
  162. Wegman ME, Egbert DS (1935) Congenital rhabdomyoma of the heart associated with arrhythmia. J Pediatr 6:818CrossRefGoogle Scholar
  163. Weinstein C, Fenoglio JJ (1987) Myocarditis. Hum Path 18:613PubMedCrossRefGoogle Scholar
  164. Weiss-Carmine S (1957) Die Endocarditis parietalis fibroplastica mit Bluteosinophilie (Löffler) und ihre Stellung im Rahmen der Parietalendokardfibrose. Schweiz med Wschr 87:890PubMedGoogle Scholar
  165. Wolff PG, Kühl U, Schultheiß H-P (1989) Laminin distribution and autoantibodies to Laminin in delated cardiomyopathy and myocarditis. Am Heart J 117:1303PubMedCrossRefGoogle Scholar
  166. Yamaguchi H, Nishijama S, Hakanishi S et al (1976) Electrocardiographic, echocardiographic and ventriculographic characterisation of hypertrophic non obstructive cardiomyopathy. Eur Heart J 4 (Suppl F):105Google Scholar
  167. Yutani C, Imakita M, Ishibashi-Ueda H et al (1985) Three autopsy cases of progression to left ventricular dilatation in patients with hypertrophic cardiomyopathy. Am Heart J 109:545PubMedCrossRefGoogle Scholar
  168. Yutani C, Imakita M, Ishibashi-Ueda H et al (1987) Histopatho-logical study of hypertrophic cardiomyopathy with progression to left ventricular dilatation. Acta Pathol Jpn 37:1041PubMedGoogle Scholar
  169. Zeviani M, Sevidei S, Gellera C et al (1989) An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 339:309PubMedCrossRefGoogle Scholar
  170. Zimmermann A, Wyss P, Stocker F (1990) Primary lipid cardiomyopathy. Virchows Arch A 416:453CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • S. Hauptmann
  • R. Poche

There are no affiliations available

Personalised recommendations